148 related articles for article (PubMed ID: 30446370)
1. C/EBP homologous protein investigation in the serum and cerebro-spinal fluid of relapsing-remitting multiple sclerosis patients.
Karami M; Aleagha MSE; Seidkhani-Nahal A; Bakhtiyari S; Noori-Zadeh A; Harirchian MH; Siroos B; Balood M; Khosravi A
J Clin Neurosci; 2019 Jan; 59():51-54. PubMed ID: 30446370
[TBL] [Abstract][Full Text] [Related]
2. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of the C-X-C motif chemokine ligand 13 and interleukin-8 in predicting the transition from clinically isolated syndrome to multiple sclerosis.
Klíčová K; Mareš J; Sobek O; Rous Z; Rous M; Raška M; Hartung HP
Eur J Neurosci; 2024 Jun; 59(11):2955-2966. PubMed ID: 38453679
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
Castellazzi M; Contini C; Tamborino C; Fasolo F; Roversi G; Seraceni S; Rizzo R; Baldi E; Tola MR; Bellini T; Granieri E; Fainardi E
J Neuroinflammation; 2014 Nov; 11():188. PubMed ID: 25391491
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
Ahlbrecht J; Martino F; Pul R; Skripuletz T; Sühs KW; Schauerte C; Yildiz Ö; Trebst C; Tasto L; Thum S; Pfanne A; Roesler R; Lauda F; Hecker M; Zettl UK; Tumani H; Thum T; Stangel M
Mult Scler; 2016 Aug; 22(9):1202-14. PubMed ID: 26493127
[TBL] [Abstract][Full Text] [Related]
7. Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis.
Takahashi K; Kurihara Y; Suzuki Y; Goshima Y; Tanaka F; Takei K
JAMA Neurol; 2015 Feb; 72(2):176-9. PubMed ID: 25437093
[TBL] [Abstract][Full Text] [Related]
8. The alterations of cerebrospinal fluid TNF-alpha and TGF-beta2 levels in early relapsing-remitting multiple sclerosis.
Grzegorski T; Iwanowski P; Kozubski W; Losy J
Immunol Res; 2022 Oct; 70(5):708-713. PubMed ID: 35729473
[TBL] [Abstract][Full Text] [Related]
9. Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.
Sisay S; Lopez-Lozano L; Mickunas M; Quiroga-Fernández A; Palace J; Warnes G; Alvarez-Lafuente R; Dua P; Meier UC
J Neuroimmunol; 2017 May; 306():40-45. PubMed ID: 28385186
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of plasma Osteopontin level in relapsing- remitting multiple sclerosis patients compared to healthy subjects in Isfahan Province.
Jafarinia M; Sadeghi E; Alsahebfosoul F; Etemadifar M; Jahanbani-Ardakani H
Int J Neurosci; 2020 May; 130(5):493-498. PubMed ID: 31795798
[No Abstract] [Full Text] [Related]
11. Serum and CSF PDGF-AA and FGF-2 in relapsing-remitting multiple sclerosis: a case-control study.
Harirchian MH; Tekieh AH; Modabbernia A; Aghamollaii V; Tafakhori A; Ghaffarpour M; Sahraian MA; Naji M; Yazdankhah M
Eur J Neurol; 2012 Feb; 19(2):241-7. PubMed ID: 21771201
[TBL] [Abstract][Full Text] [Related]
12. Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica.
Tortorella C; Ruggieri M; Di Monte E; Ceci E; Iaffaldano P; Direnzo V; Mastrapasqua M; Frigeri A; Amato MP; Hakiki B; Ghezzi A; Lugaresi A; De Luca G; Patti F; D'Amico E; Sola P; Simone AM; Svelto M; Livrea P; Trojano M
J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1355-9. PubMed ID: 21622936
[TBL] [Abstract][Full Text] [Related]
13. Serum Phosphorylated Neurofilament Heavy Chain Level in Relapsing Remitting Multiple Sclerosis in Correlation to Disease Activity and Disability.
Shehab AA; Solima DA; Abdel-Hafeez MA; Mohamed SM
Egypt J Immunol; 2019 Jan; 26(1):1-13. PubMed ID: 31332992
[TBL] [Abstract][Full Text] [Related]
14. The patients with clinically isolated syndrome and relapsing remitting multiple sclerosis show different levels of advanced protein oxidation products and total thiol content in plasma and CSF.
Ljubisavljevic S; Stojanovic I; Vojinovic S; Stojanov D; Stojanovic S; Cvetkovic T; Savic D; Pavlovic D
Neurochem Int; 2013 Jun; 62(7):988-97. PubMed ID: 23500606
[TBL] [Abstract][Full Text] [Related]
15. Decreased concentration of Klotho in the cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.
Emami Aleagha MS; Siroos B; Ahmadi M; Balood M; Palangi A; Haghighi AN; Harirchian MH
J Neuroimmunol; 2015 Apr; 281():5-8. PubMed ID: 25867461
[TBL] [Abstract][Full Text] [Related]
16. Elevated CSF concentration of CCL3 and CCL4 in relapsing remitting multiple sclerosis patients.
Soleimani M; Soleymani A; Seyyedirad N
J Immunoassay Immunochem; 2019; 40(4):378-385. PubMed ID: 31268406
[TBL] [Abstract][Full Text] [Related]
17. Plasma Interleukin-33 level in relapsing-remitting multiple sclerosis. Is it negatively correlated with central nervous system lesions in patients with mild disability?
Mado H; Adamczyk-Sowa M; Bartman W; Wierzbicki K; Tadeusiak B; Sowa P
Clin Neurol Neurosurg; 2021 Jul; 206():106700. PubMed ID: 34030079
[TBL] [Abstract][Full Text] [Related]
18. Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.
Novakova L; Axelsson M; Malmeström C; Zetterberg H; Björkhem I; Karrenbauer VD; Lycke J
J Neurol Sci; 2015 Nov; 358(1-2):201-6. PubMed ID: 26342940
[TBL] [Abstract][Full Text] [Related]
19. Serum and cerebrospinal fluid prolactin levels in male and female patients with clinically-isolated syndrome or relapsing-remitting multiple sclerosis.
Markianos M; Koutsis G; Evangelopoulos ME; Mandellos D; Sfagos C
J Neuroendocrinol; 2010 Jun; 22(6):503-8. PubMed ID: 20236233
[TBL] [Abstract][Full Text] [Related]
20. Serum endocan levels in multiple sclerosis relapse and remission.
Akil E; Alp R; Aluclu MU; Acar A; Kaplan I
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4091-4098. PubMed ID: 34156688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
